Equities researchers at Cowen and Company hoisted their price target on shares of LDR Holding Corp (NASDAQ:LDRH) from $25.00 to $34.00 in a research report issued on Friday, AR Network reports. Cowen and Company’s price objective points to a potential upside of 7.77% from the stocks previous close. LDR Holding Corp (NASDAQ:LDRH) stock opened at $37.40 in last session, and closed at $39.44, while the day range of LDR Holding Corp (NASDAQ:LDRH) stock is $33.38 – $40.00. The stock showed a positive weekly performance of 16.65%.
On February 21, 2014, the company’s Board of Directors, based on the recommendation of their Compensation Committee, approved 2013 incentive cash bonus payments to their executive officers. The bonus payments were based on an assessment of achievement of corporate goals established earlier in the year. Xencor Inc. (NASDAQ:XNCR) stock opened at $13.65 in last session, and closed at $13.90 by gaining 1.76%. The 52 week range of $5.75 – $14.34. Company’s market capitalization is $380.76 million.
The option for cheaper finance is luring RadNet Inc. (NASDAQ:RDNT) to refinance its costly $200 million worth senior notes due in 2018. RadNet Inc. (NASDAQ:RDNT) stock increased 0.00% and finished the last session at $2.90. The EPS of the stock remained 1.34. Company’s market capitalization is $113.78 million.
Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) is seeking to develop and commercialize diagnostic tests based on discovered group of genes known as microRNAs. The Company has established a clinical laboratory improvement amendment (CLIA)-certified laboratory in Philadelphia, which enables it to develop, validate and commercialize its own diagnostic tests applying its microRNA technology. Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) stock opened the session at $5.84, and closed the session at $6.09. The 52 week range of the Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) stock remained $2.35 – $6.60 and the day range was $5.82 – $6.23.